There is need for alternative treatment to circumvent current treatment limitations
Iyza F. Baig
Advertisement
Articles by Iyza F. Baig
Treatment should focus on the underlying etiology behind these processes
Advertisement
Latest Updated Articles
- Exploring tocilizumab for giant cell arteritis cases
Published: August 27th 2018 | Updated:
When autoimmune diseases exert neuro-ophthalmic effectsPublished: September 25th 2018 | Updated:
Considering use of teprotumumab in thyroid eye disease patientsPublished: October 22nd 2018 | Updated:
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
STAAR and Broadwood conflict over proposed Alcon merger continues
2
FDA clears IND for Complement Therapeutics’ CTx001 gene therapy in geographic atrophy
3
Finding your fit: Excimer lasers and early surgical practice
4
Ocular surface: Targeted therapies for a multifactorial problem
5
.png "Optometry Times"){kind=logo}
